Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.

Discov Oncol · 2022 · PMC9755453 · PMID 36522513

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

narrowly missed significancep = 0.056so close (0.05 < p ≤ 0.1)

In the mCRPC (cabazitaxel) cohort, NLR3 narrowly missed significance ( p = 0.056) in logistic regression analysis when associated with 3-year-, 5-year- and overall survival.

also in 112 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.